Ozone, Chikafumi
25  results:
Search for persons X
?
1

Possible Advantage of Glucagon-Like Peptide 1 Receptor Agon..:

Sato, Tetsuhiko ; Azuma, Yoshinori ; Ozone, Chikafumi...
The Journal of Clinical Endocrinology & Metabolism.  108 (2023)  10 - p. 2597-2603 , 2023
 
?
2

ODP083 Burosumab Treatment for Fibrous dysplasia/McCune-Alb..:

Sato, Tetsuhiko ; Azuma, Yoshinori ; Tauchi, Ryoji..
Journal of the Endocrine Society.  6 (2022)  Supplement_1 - p. A160-A160 , 2022
 
?
4

A Possible Advantage of Glucagon-Like Peptide 1 Receptor Ag..:

Sato, Tetsuhiko ; Ohara, Emi ; Ozone, Chikafumi...
Journal of the Endocrine Society.  5 (2021)  Supplement_1 - p. A405-A406 , 2021
 
?
 
?
14

A new primate model of hypophyseal dysfunction:

Kawabata, Teppei ; Suga, Hidetaka ; Takeuchi, Kazuhito...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144576/.  , 2021
 
?
 
1-15